Free Trial
Steve Silver

Steve Silver Analyst Performance

Security Analyst at Argus

Steve Silver is a stock analyst at Argus in the medical sector, covering 2 publicly traded companies. Over the past year, Steve Silver has issued 3 stock ratings, including and buy recommendations. While full access to Steve Silver's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Steve Silver's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
3 Last 0 Years
Buy Recommendations
100.00% 3 Buy Ratings
Companies Covered
2 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy100.0%3 ratings
Hold0.0%0 ratings
Sell0.0%0 ratings

the majority (100.0%) have been Buy recommendations.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
50.0% of companies on NYSE
1 company
NASDAQ
50.0% of companies on NASDAQ
1 company

Steve Silver, an analyst at Argus, currently covers 2 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
2 companies
100.0%

Steve Silver of Argus specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
1 company
50.0%
MED INSTRUMENTS
1 company
50.0%

About Steve Silver

Steve began working with Argus Research in 2018. He is a generalist, responsible for analytical coverage of global companies, primarily within the Healthcare, Consumer, Industrial, and Technology sectors. Prior to Argus, Steve specialized in the Healthcare sector for more than a decade, as an investor relations professional and a Wall Street professional, and as a Senior Equity Analyst covering the biotechnology/healthcare facilities industries for S&P Capital IQ. At S&P, Steve frequently conducted broadcast and print media interviews to enhance brand visibility and thought leadership position, and has appeared in media outlets including CNBC, Fox Business, Bloomberg, and The Wall Street Journal. Steve holds an MBA with concentrations in Investment Management/Strategic Leadership from Penn State University.
Follow on LinkedIn

Steve Silver's Ratings History at Argus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
CVS Health Corporation stock logo
CVS
CVS Health
1/28/2026Lower Price Target$73.86$90.00Buy
DexCom, Inc. stock logo
DXCM
DexCom
11/7/2025Lower Price Target$54.94$90.00Buy
DexCom, Inc. stock logo
DXCM
DexCom
8/21/2025Initiated Coverage$81.67$100.00Buy